Gilead Sciences

Kelley Paul lost money on the investment in Gilead Sciences, which makes an antiviral drug used to treat COVID-19, a spokesperson said.
Coronavirus patients around the world have been rushing to join remdesivir studies that opened in hospitals in the last few weeks.